Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence

Robert Marek Radkowski, Sabine Haase, Brigitte Schlegelberger, MD, PhD, Gudrun Goehring, Stefanie Banisch, MD, Michael Heinsch, Carlo Aul, Aristoteles Giagounidis

Blood (2010) 116 (21): 2923.

https://doi.org/10.1182/blood.V116.21.2923.2923

Published: 2010

Journal Articles

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy

Georg Russwurm, Michael Heinsch, Robert Radkowski, Rainer Erlemann, Carlo Aul, Sabine Haase, Aristoteles Giagounidis

Blood (2010) 116 (14): 2617–2618.

https://doi.org/10.1182/blood-2010-04-279786

Published: 2010

Journal Articles

Discontinuation of Lenalidomide in Patients with Transfusion-Dependent Low- and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5q): Sustained Remissions, but Not Cure.

Aristoteles Giagounidis, Gudrun Göhring, MD, Sabine Haase, Carlo Aul, Brigitte Schlegelberger, M.D., Andrea Kuendgen, Regina Herbst, MD, Gerhard Ehninger, Uwe Platzbecker

Blood (2009) 114 (22): 3807.

https://doi.org/10.1182/blood.V114.22.3807.3807

Published: 2009

Journal Articles

Risk Factors for Disease Progression in del(5q) MDS Patients Treated with Lenalidomide.

Aristoteles A. Giagounidis, MD, Sabine Haase, Uwe Platzbecker, MD PhD, Ulrich Germing, MD PhD, Vera Lohrbacher, Gerhard Ehninger, MD PhD, Carlo Aul, MD PhD

Blood (2007) 110 (11): 1460.

https://doi.org/10.1182/blood.V110.11.1460.1460

Published: 2007

Journal Articles

Lenalidomide Is Likely To Improve Overall Survival in Patients with del(5q) Myelodysplastic Syndrome with a Complex Karyotype.

Aristoteles A. Giagounidis, MD, Sabine Haase, Ulrich Germing, MD PhD, Gundula Göhring-Michaelsen, Brigitte Schlegelberger, MD PhD, Carlo Aul, MD PhD

Blood (2006) 108 (11): 4860.

https://doi.org/10.1182/blood.V108.11.4860.4860

Published: 2006

Journal Articles

Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α.

Aristoteles A.N. Giagounidis, MD, Sabine Haase, Ulrich Germing, MD, PhD, Claudia Schoch, MD, PhD, Brigitte Schlegelberger, PhD, Ludwig Wilkens, PhD, Guntram Büsche, MD, Hans H. Kreipe, MD, PhD, Manuel Aivado, MD, Michael Lübbert, MD, PhD, Arnold Ganser, MD, PhD, Carlo Aul, MD, PhD

Blood (2004) 104 (11): 4729.

https://doi.org/10.1182/blood.V104.11.4729.4729

Published: 2004

NARROW

Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy

Discontinuation of Lenalidomide in Patients with Transfusion-Dependent Low- and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5q): Sustained Remissions, but Not Cure.

Risk Factors for Disease Progression in del(5q) MDS Patients Treated with Lenalidomide.

Lenalidomide Is Likely To Improve Overall Survival in Patients with del(5q) Myelodysplastic Syndrome with a Complex Karyotype.

Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α.

Email alerts

ASH Publications

American Society of Hematology

Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy

Discontinuation of Lenalidomide in Patients with Transfusion-Dependent Low- and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5q): Sustained Remissions, but Not Cure.

Risk Factors for Disease Progression in del(5q) MDS Patients Treated with Lenalidomide.

Lenalidomide Is Likely To Improve Overall Survival in Patients with del(5q) Myelodysplastic Syndrome with a Complex Karyotype.

Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only